Everolimus in de Novo Heart Transplant Recipients

NCT01017029 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac Transplantation

Interventions

DRUG: Everolimus
DRUG: Mycophenolate mofetil + Everolimus

Sponsor

Novartis Pharmaceuticals